Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Guidant Corporation |
---|---|
Information provided by: | Guidant Corporation |
ClinicalTrials.gov Identifier: | NCT00180375 |
This study evaluates the date of the first appropriate and/or inappropriate therapy in patients implanted with a Guidant PRIZM or VITALITY defibrillator and is evaluating eventual predictive risk factors for appropriate/inappropriate therapies as well as the influence of the programmed parameters on these therapies.
Condition | Intervention | Phase |
---|---|---|
Ventricular Tachycardia Ventricular Fibrillation |
Device: Prizm, Vitality, Renewal |
Phase IV |
Study Type: | Observational |
Study Design: | Prospective |
Official Title: | OPERA: French Observational Study on Patients Implanted With a Guidant PRIZM or Vitality Defibrillator |
Estimated Enrollment: | 700 |
Study Start Date: | May 2002 |
Study Completion Date: | August 2007 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
France | |
CHU Pontchaillou | |
Rennes, France, 35033 | |
CHU Michalon | |
Grenoble, France, 38043 | |
CHU Angers | |
Angers, France, 49033 | |
CHU Tours | |
Tours, France, 37044 | |
CHU Montpellier | |
Montpellier, France, 34295 | |
CHU Nantes | |
Nantes, France, 34295 | |
CHU Rangueil | |
Toulouse, France, 31403 | |
CHU Rouen | |
Rouen, France, 76031 | |
CHU Clermont Ferrand | |
Clermont Ferrand, France, 63003 | |
GH La Timone | |
Marseille, France, 13385 | |
CH St. Joseph | |
Marseille, France, 13008 | |
CH Amiens | |
Amiens, France, 80054 | |
CH Besancon | |
Besancon, France, 25030 | |
CHG Chateauroux | |
Chateauroux, France, 36019 | |
CHU Hopital la Cavale Blanche | |
Brest, France, 29609 | |
CH La Roche sur Yon | |
La Roche sur Yon, France, 85025 | |
CHU Toulon | |
Toulon, France, 83056 | |
CHU Dupuytren | |
Limoges, France, 87042 | |
Hopital Antoine Beclere | |
Clamart, France, 92140 | |
Hopital Angouleme | |
Angouleme, France, 16470 | |
Hopital Nord | |
Marseille, France, 13915 | |
Hopital Neuro-cardiologique | |
Lyon, France, 69394 | |
Hopital Cote de Nacre | |
Caen, France, 14033 | |
CHRU Robert Debré | |
Reims, France, 51092 | |
CH Avignon | |
Avignon, France, 84902 | |
CMC Arnaud Tzanck | |
St. Laurent du Var, France, 6700 | |
CHG Aix en Provence | |
Aix en Provence, France, 13616 | |
Hôpital Princesse de Grâce | |
Monaco, France, 98000 | |
CHG Albi | |
Albi, France, 81000 | |
CHG Pau | |
Pau, France, 64046 | |
CHU Nice | |
Nice, France, 6002 | |
CHG Martigues | |
Martigues, France, 13696 | |
CHU D'Orleans | |
Orleans, France, 45000 |
Principal Investigator: | Antoine LEENHARD, MD | Hôpital Lariboisière, Paris |
Responsible Party: | Guidant France ( Elisabeth Mouton ) |
Study ID Numbers: | OPERA Registry, 902194 |
Study First Received: | September 12, 2005 |
Last Updated: | December 12, 2007 |
ClinicalTrials.gov Identifier: | NCT00180375 |
Health Authority: | France: Afssaps - French Health Products Safety Agency |
Heart Diseases Tachycardia Paroxysmal ventricular fibrillation |
Tachycardia, Ventricular Ventricular Fibrillation Arrhythmias, Cardiac |
Pathologic Processes Cardiovascular Diseases |